Summary
The Smoothened (Smo) signalling pathway participates in many developmental processes, contributing to the regulation of gene expression by controlling the activity of transcription factors belonging to the Gli family. The key elements of the pathway were identified by means of genetic screens carried out in Drosophila, and subsequent analysis in other model organisms revealed a high degree of conservation in both the proteins involved and in their molecular interactions. Recent analysis of the pathway, using a combination of biochemical and cell biological approaches, is uncovering the intricacies of Smo signalling, placing its elements in particular cellular compartments and qualifying the molecular processes involved. These include the synthesis, secretion and diffusion of the ligand, the activation of the receptor and the modifications in the activity of nuclear effectors. In this review we discuss recent advances in understanding biochemical and cellular aspects of Smo signalling, with particular focus in the similarities in the mechanism of signal transduction between Smo and other transmembrane proteins belonging to the G-Protein coupled receptors superfamily
Biological roles of Hh/Smo signalling during development and disease
The components of the Smo signalling pathway were identified by their similar requirements during embryonic segmentation and appendage development in Drosophila [1, 2] . Since then, the number and variety of developmental processes requiring Smo function has increased enormously, both in Drosophila and vertebrates [3] [4] [5] [6] [7] . Most often Smo functions during embryonic development, in processes such as digit patterning in the chick limb bud and left-right asymmetry of vertebrate embryos.
In addition, Smo function is also fundamental for the maintenance of tissue homeostasis in adults, and deregulated Smo signalling is implicated in tumorogenesis. Most of the elements of the Smo pathway have been identified through genetic screenings carried out in Drosophila and, more recently, by the use of systematic searches in cell culture experiments [8, 9] . Simultaneously, the use of biochemical approaches has unravelled many of the complexities of the pathway, allowing a partial understanding of the molecular interactions that translate the binding of the ligand Hedgehog (Hh) to its receptor Patched (Ptc) into the functional state of the transcription factor Cubitus interruptus (Ci), and hence to the regulation of gene expression in response to Hh [10] .
Most of the elements of the pathway are conserved from flies to vertebrates, the main difference being the number of related genes present in different organisms [7] .
Thus, there is only one Hh gene in flies and three Hh-related genes in vertebrates, sonichedgehog, desert-hedgehog and indian-hedghog, which are expressed in different tissues and stages of development [11] . Similarly, there is only one gene encoding the receptor Ptc in Drosophila and two Ptc proteins (PTC1 and PTC2) in vertebrates ( Table   1 ). The main effectors of Smo signalling, the Gli proteins related to Drosophila Ci, are also conserved in vertebrates, where at least three Gli proteins are found (GLI1, GLI2 and GLI3). In the mouse, these proteins mediate all Hh-dependent patterning in the neural tube [12, 13] . Like Ci, all three vertebrate Gli proteins have five highly conserved zinc finger DNA binding domains and C-terminal activation domains, with Gli2 and Gli3 also having N-terminal repressor domains [12, 14] . Gli3 truncations, point mutations, and frame shifts changes in human Gli3 lead to a variety of diseases including Greig cephalopolysyndactyly syndrome (GCPS) [15] [16] [17] , Pallister-Hall syndrome (PHS) [18] , and postaxial polydactyly type A (PAP-A) [19] .
Despite the conservation in the components of Smo pathway during evolution, some caveats remain as to the preservation of the key molecular mechanisms operating in different organisms [20] . Particularly perplexing has been the difficulties in relating the mechanisms of Smo signal transduction to that of other transmembrane proteins with a similar molecular structure, the G-protein coupled receptor (GPCR) superfamily of seven transmembrane domains proteins.
In this review we will summarize recent advances in the identification of the molecular mechanisms involved in Smo signal transduction, emphasizing the relationships between Smo and other GPCRs, and the participation in Smo signalling of several components of classic GPCR pathways, such as heterotrimeric G-proteins, β-arrestins and G-protein coupled receptor kinases (GRKs).
The elements of the Smo signalling pathway and the mechanisms of Smo signal transduction.
The core members of the Smo signalling pathway include the ligand (Hedgehog, Hh), the receptor (Patched, Ptc), several transducers such as Smoothened (Smo) and the cytoplasmic complex formed by the kinesin-like protein Costal-2 (Cos2), the serine/threonine kinase Fused (Fu), the novel protein Suppressor of fused [Su(fu)], and the transcription factor Cubitus interruptus (Ci) [7, 21] . In addition, several proteins participate in the correct secretion and movement of active Hh, in the phosphorylation of Ci and Cos2, and in the processing and degradation of Ci [21, 22] . In this manner, the Smo pathway can be sub-divided into several "molecular modules" participating in (i) the formation, secretion and movement of active Hh, (ii) the intracellular trafficking, sorting and recycling of Hh/Ptc/Smo complexes, (iii) the relay complex formed by Cos2, Fu, Ci and in some instances Su(fu), and (iv) the enzymatic machinery that by phosphorylation (GSK3, CKI and PKA) or proteolysis (Slimb) modulates the activities of Smo, Cos2, Fu and Ci (Table 1 and Fig. 1 ).
The final outcome of Smo signalling consists in modifications to the stability, phosphorylation and subcellular localisation of the transcription factor Ci/Gli, in a process regulated by post-transcriptional modifications to Ci. The transition of Ci from the "inactive" state (repressor form), defined by the presence in the nucleus of the processed form Ci-75 and the cytoplasmic accumulation of Ci (Fig. 1A) , to the "active" state (activator form), characterized by the presence in the nucleus of full-length Ci-155 and the absence of Ci-75, is triggered by interaction between the receptor Ptc and the ligands of the Hedgehog (Hh) family ( Figure 1B ). These ligands are secreted proteins synthesized as precursors containing a signal peptide, and possess auto-proteolytic activity [7] ( Figure 1C ). In addition, after its synthesis and before their apical secretion to the extracellular space, Hh proteins are modified by the addition of lipid molecules [22] . Thus, Hh is cleaved in an autoproteolytic reaction and a cholesterol molecule is incorporated in its C terminus of the N-terminal fragment, giving rise to the Hh-Np active form [22] . A second lipid modification is the addition of palmitic acid the N terminus of Hh-Np, in a reaction catalysed by the acyl transferase Rasp [23, 24] . The analysis of mutated forms of Hh in flies suggests that absence of cholesterolmodification in Hh-Np affects its secretion, multimerization and long-range signalling activity [25, 26] , as was previously recognized in mammalian systems [27] [28] [29] .
Similarly, the lack of acylation reduces dramatically Hh signalling, both in Drosophila and vertebrates.
Once Hh is modified by lipids, it must be secreted to the extracellular space. It has been shown that the protein encoded by the gene dispatched (disp) is required to liberate lipid-modified Hh from Hh producing-cells [27, 30] . Thus, disp mutant cells retain lipid-modified Hh, whereas unmodified Hh-N is secreted independently of Disp function. Disp contains, like Ptc, twelve transmembrane domains and a sterol-sensing domain (SSD), which has been involved in cholesterol homeostasis and cholesterollinked signalling [22] .
Hh interacts with the twelve-pass transmembrane receptor Patched (Ptc) of neighbouring cells, and the range of Hh diffusion and effectiveness varies in different developmental systems [31] [32] [33] [34] [35] . Extracellular matrix proteins such as heparan sulfate proteoglycans (HSPGs) participate in the movements of Hh once it has been secreted, and might contribute to the presentation of Hh to its receptor Ptc. Thus, the Drosophila EXT family of proteins encoded by the genes tout velu (ttv), brother of tout velu (botv) and sister of tout velu (sotv) are essential for the synthesis of HSPGs and are required for the diffusion of lipid-modified Hh [36, 37] . The proteins Dally and Dally-like (Dlp) are glypicans forming the HSPGs core, and are also required for Hh diffusion [38, 39] .
Another protein recently implicated in the spreading of Hh is a secreted protein encoded by the gene shifted (shf), that is required for normal accumulation of Hh in the extracellular matrix of Hh-producing cells and for lipid-modified Hh diffusion [40, 41] .
Shf is the ortholog of the human Wnt inhibitory factor (WIF), a secreted antagonist of the Wingless pathway. However, Shf has not effect on Wingless activity in Drosophila.
Finally Megalin, a multi-domain transmembrane protein [42] , and a novel and evolutionarily conserved family of transmembrane proteins containing Ig domains and two extracellular fibronectin type III domains, CDO and BOC, bind to Hh, and might function as co-receptors in Hh reception [43] [44] [45] . [51] . Thus, after entering late endosomes together, Smo is segregated from the Ptc-Shh complex, and returns to the cell surface, where it is now ready to signal [51] . Interestingly, constitutively active mutant Smo proteins that are not inhibited by Ptc (isolated from sporadic basal cell carcinomas), fail to co-localise and co-internalise with Ptc, allowing the activation of the pathway independently of Hh [50] . (Fig. 1B) . This leads to the disassembly of Cos2-Ci-kinase complexes. As a consequence, Ci phosphorylation is compromised and Ci processing does not take place, allowing the accumulation of the full-length form of Ci (Ci-155) in the cytoplasm and its entrance into the nucleus [55] [56] [57] [58] [59] [60] . A significant fraction of Su(fu) associates with Ci, whereas a smaller fraction may also associate with Cos2 and Fu, in at least two distinct complexes, one comprising Ci/Su(fu) and another Cos2/Fu/Ci/Su(fu) [61] . In this scenario, Cos2 plays a key role in the transition from Ci-75 to Ci-155 through interactions with Smo. Early studies of Cos2 identified a negative role for Cos2 in pathway regulation, because cos2 mutations caused inappropriate activation of signalling [62, 63] . This antagonism is due to the requirement of Cos2 for both cytoplasmic retention of Ci and its proteolytic processing to produce Ci-75 [64] [65] [66] . 
Smoothened as a member of the GPCR family
The super-family of G-protein coupled receptors (GPCRs) is one of the largest families of proteins in vertebrates, with circa 1000 genes encoding for such receptors identified in the human genome [67] [68] [69] . GPCRs participate in a variety of important physiological functions and are targets for many drugs. The ligands that activate GPCRs are molecularly diverse, and include ions, organic odorants, amines, peptides, proteins, lipids, and nucleotides. In addition many GPCRs have also been denominated 'orphan receptors', because their natural ligands have escaped identification so far [13] . The main structural characteristic of the family is the seven membrane-spanning -helices (TMHs), which span the membrane in an anti-clockwise manner and are formed by 25-35 consecutive amino acid residues with some degree of hydrophobicity. These helices are connected by extracellular and intracellular hydrophilic loops, with an extracellular N-terminus and a cytoplasmic C-terminus. Most GPCRs, as its name indicates, mediate their intracellular actions through pathways involving interaction and activation of heterotrimeric G-proteins, although G-protein-independent signaling mechanisms have also been reported for some GPCRs. In addition several non-GPCR receptors use heterotrimeric G-proteins and other cytoplasmic proteins related to GPCR activity as transducers in their signaling. For these reasons, some authors used alternative names for this protein superfamily such as "7-transmembrane receptors", "serpentine-like receptors" or "heptahelical receptors" [70] [71] [72] The CRD domain may also be required for the interaction between Smo and Ptc. In this sense, some reports have shown a weak interaction between PTC and the CRD of Smo, and both proteins can be co-inmunoprecipitated when over-expressed [81] . Direct interactions between Smo and Ptc, however, have not been detected under physiological conditions [82] , probably reflecting that this interaction is weak and transient. In addition, Ptc and Smo show minimal co-localisation within the cell, and their interaction is not stechiometric, as Ptc is able to inhibit excess of Smo [46, 50, 82, 83] ).
Other motifs of homology with the Secretin family shared by Smo and Fz are located between the transmembrane regions of these proteins.
Seven-transmembrane receptors dimerization
GPCRs have traditionally been thought to act as monomers, but now is widely accepted that GPCRs may exist as either homodimers or even higher-order oligomers.
They are also capable of interacting with distantly related receptor subtypes to form hetero-oligomers and, for many members of this receptor family, the dimer may represent the basic signaling unit during their normal intracellular trafficking and function (reviewed in [84] [85] [86] . Certain GPCRs seem to have a strict requirement for heterodimerization to attain proper surface expression and functional activity such as the GABA B receptor [87] . Heterodimerization can also lead to marked changes in receptor pharmacology, signaling, and/or internalisation.
There is not direct data demonstrating Smo dimerization, but several observations concerning Smo and the related Frizzled (Fz) receptors suggest that they also operate as dimers or multimers. Thus, ectopic expression of Smo variants with Cterminal deletions cause dominant-negative effects, and increased expression of fulllength Smo results in ectopic activation of the pathway [88] . More recently, it has been hypothesized that the highest level of Smo activity might involve Smo dimerization [89] . Smo dimers would interact with Cos2-Fu-Ci-Su(fu) complexes, activating Su(fu) phosphorylation by Fu, and releasing the inhibition on Ci.
Coupling of Smo to heterotrimeric G-proteins
There are several evidences pointing to a role of heterotrimeric G-proteins as Smo effectors in vertebrates. First, Smo is constitutively active in the absence of Ptc, and the third intracellular loop and the seventh transmembrane region of Smo are required for this function [90] . Both domains are very important in other GPCRs for coupling with heterotrimeric G-proteins. Assays made in frog melonophores expressing human Smo showed a phenotype of persistent pigment aggregation, and this effect can be blocked by pertussis toxin [91] , a treatment known to ADP-ribosylate a cysteine residue near the carboxyl terminus of Gαi or Gαo, disrupting receptor-G protein coupling [92] . These results suggest that Smo can signal through heterotrimeric G-proteins. In fact, it has been recently shown that Smo activates all members of the Gαi family, and this effect is an essential component of Gli activation in mammalian fibroblasts [93] . In the same line, injection of Zebrafish embryos with RNA encoding pertussis toxin and therefore blocking Gαi-mediated actions suggests a possible role for in Smo signaling [94] .
Further support for a role of heterotrimeric G proteins in Smo signal transduction is the reported transcriptional stimulation of a Gli1 promoter in HEK293 and N2a cells overexpressing constitutively active Gα [95] .
These data reveal that the However other data suggest that G-proteins are not always required for Smo signaling. In vitro studies using a primary fish myoblast assay system reveal that the response to Shh is insensitive to pertussis toxin treatment. Moreover, there is to date no report of mutations in a Drosophila G-protein giving a phenotype reminiscent of Smo signaling disruption [94] , and studies using RNA interference to inhibit a full spectrum 
Smo phosphorylation
Drosophila Smo activation is accompanied by its phosphorylation, accumulation and translocation to the plasma membrane [46, 50, 59, [98] [99] [100] . When Hh is present, the Smo C-terminal tail becomes hyper-phosphorylated by protein kinase A (PKA) and
Casein kinase I (CKI) (see Fig 1B) . Loss of these PKA or CK1 sites, using un- Interestingly, a Drosophila Smo mutant with acidic residues in place of PKA and CK1-targeted serine residues can be further activated by Hh treatment, indicating that additional changes in Smo can be induced by Hh, conceivably involving additional phosphorylation sites [98] [99] [100] . Some of those identified residues are in the vicinity of acidic residues that fit a "GRKs phosphorylation consensus-sequence" observed in both plasma membrane receptors and cytoplasmic substrates of GRK2 [102] [103] [104] [105] [106] . Some of these phosphorylated residues are present both in Drosophila and in vertebrate Smo C- Internalised receptors can then be dephosphorylated by the action of specific phosphatases in low pH endosomes and recycled to the plasma membrane (resensitization), or be degraded in lysosomes [101, [108] [109] [110] . In addition, binding of β-arrestins can recruit additional proteins to the membrane, acting as signal transducers through the formation of scaffolding complexes with accessory effector molecules such as Src, Raf, ERK1/2, JNK3, MAPK4 and p38 [111] [112] [113] [114] [115] [116] .
The implication of β-arrestin and GRKs in modulating protein activity and localisation is not exclusive to GPCRs. For example, the non-visual arrestin of Drosophila encoded by Kurtz interacts with the putative E3 ubiquitin ligase Deltex, and promotes ubiquitination and degradation of the Notch receptor [117] . Arrestin also constitutes an essential component in the signaling pathways initiated by the insulin-like growth factor 1 (IGF-1) by promoting ubiquitination of the receptor by the E3 ubiquitin ligase oncoprotein MDM2 [116] . β-arrestin2 can also bind to the single transmembrane-spanning type II TGF receptor, and its binding is triggered by receptor auto-phosphorylation [101, 105] .
In addition to arrestin, GRK proteins have also been involved in the modulation of both non-GPCR receptors and other non-receptor proteins. Thus, GRKs are able to phosphorylate non-receptor substrates such as tubulin, synucleins, phosducin, ribosomal protein P2, the inhibitory -subunit of the type 6 retinal cGMP phosphoriesterase, a subunit of the epithelial Na + -channel and ezrin [68, 102, 105, 106, [118] [119] [120] [121] . GRKs also participate in several pathways and modulate cellular functions in a phosphorylation-independent manner. These actions of GRKs are due to their ability to interact with a variety of proteins involved in signaling and trafficking, such as Gαq, Gβ , caveolin, or GIT [122] [123] [124] . Finally, arrestins and GRKs also participate in several signaling platforms regulating other receptor families, such as tyrosine kinase receptors [125, 126] .
The secretin receptor, belonging to the same family of GPCR as Smo and Fz, can be phosphorylated by GRK2 and GRK5 upon binding of agonists, promoting its desensitization [127] . Secretin is not the only member of this family that becames phosphorylated by GRKs upon agonist stimulation. Smo over-expression in mammalian cultured cells recruits β-arrestin2 to the plasma membrane [101] . A regulatory role for β-arrestin 2 in the Hh signaling pathway has also been described in vivo. Thus, functional knockdown of β-arrestin 2 by morpholino depletion in zebrafish embryos lead to phenotypes similar to those resulting from mutants in the Hh pathway, indicating a functional interaction between β-arrestin2 and Smo [107] . This interaction was demonstrated in mammalian cell culture experiments, which showed that both β-arrestin and GRK2 mediate clathrin-dependent internalisation of active Smo.
Furthermore, Ptc, as well as the antagonist cyclopamine, inhibits the association of β-arrestin 2 with Smo, and this inhibition is relieved in cells treated with the agonist Shh [101] . Finally, a direct requirement of mammalian GRK2 in Smo signalling has been identified in C3H10TI/2 cells, where GRK2 promotes coupling of β−arrestin and Smo [128] . Because the integrity of the Smo C-terminal, in addition to G-protein coupling, is necessary for Gli activation [93] , it is tempting to speculate that GRK2 activity acting through the Smo C-terminal domain is a key component of Smo pathway activation.
The vertebrate β-arrestins and GRK proteins have homologous genes in
Drosophila, although their functional characterisation has not yet being reported for most of them. There are two GRKs in Drosophila, GPRK1 and GPRK2, which share homology with members of the mammalians subfamilies 2 and 4, respectively. GPRK1
(more similar in sequence to mammalian GRK2 and GRK3) modulates the amplitude of the visual response acting as a Rhodopsin kinase [129] . GPRK2 has higher sequence identity with mammalian members of the GRK4 subfamily (GRK4-6), and its function is required to regulate the level of cAMP during Drosophila oogenesis [130, 131] .
Recent work in our laboratory using the Drosophila model revealed that when Grpk2 levels are lowered the function of Smo is impaired. Thus, flies expressing interference RNA directed against GPRK2 display a phenotype similar to that characteristic of Smo loss-of-function alleles [132] . Furthermore, loss of GPRK2 also affects Smo protein localisation and stability, suggesting that GPKK2 is required for the correct activation of Smo [132] . So far, no Drosophila β−arrestin homolog has been reported to affect Hh signaling. In this regard, in vivo studies in vertebrates also have shown that β−arrestin 2 acts as a positive regulator of the Hh pathway that in zebrafish [107] . However, there are no data concerning the role of β−arrestin and GRKs during mammalian development. Mice lacking either β-arrestin 1 or β-arrestin 2 are viable, whereas those lacking both are embryonic lethal [133] , although the double-mutant embryos have to our knowledge not been examined for defects in Hh signaling. Mice lacking Grk2 die between embryonic day (E) 9.0 and E15.5 with heart abnormalities [134] , but again analysis of a potential Hh/Smo signaling-realated phenotype has not been reported. [3-7, 10, 11, 20, 22, 42-45, 90] and for Gprk2 in flies [132] . 
